Approval · Notice of Compliance 4160 · 1997
ODRIK: Notice of Compliance 4160
Issued May 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4160
- Date
- May 15, 1997
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ODRIK | 02231292 | — |
| ODRIK | 02231293 | — |
| ODRIK | 02231294 | — |
Medicinal ingredients
- TRANDOLAPRIL 0.5 MG per CAP
- TRANDOLAPRIL 1 MG per CAP
- TRANDOLAPRIL 2 MG per CAP